The effect of some selective agonists and antagonists on peripheral muscarinic receptors. 1988

A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson

UI MeSH Term Description Entries
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010277 Parasympathomimetics Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. Parasympathomimetic Agents,Parasympathomimetic Drugs,Parasympathomimetic Effect,Parasympathomimetic Effects,Agents, Parasympathomimetic,Drugs, Parasympathomimetic,Effect, Parasympathomimetic,Effects, Parasympathomimetic
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
February 1996, Pharmacology & toxicology,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
January 1989, Naunyn-Schmiedeberg's archives of pharmacology,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
January 1976, Journal of supramolecular structure,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
October 1983, The Biochemical journal,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
October 1989, Farmaco (Societa chimica italiana : 1989),
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
July 2021, Pharmacological research,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
January 2006, Journal of molecular neuroscience : MN,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
February 1991, Indian journal of experimental biology,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
January 1995, Life sciences,
A L Gardner, and S A Darroch, and L K Choo, and F Mitchelson
April 2002, Mini reviews in medicinal chemistry,
Copied contents to your clipboard!